<div id="readability-page-1">Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from $95. The shares were still rated as a buy by analyst Kyle Mikson. As noted by Canaccord, the sector momentum that […]</div>

<p>Canaccord 已將 Tempus AI, Inc.（NASDAQ:TEM）的目標股價從 95 美元下調至 80 美元，同時維持對該股票的 “買入” 評級。根據 TheFly 在 2025 年 12 月 22 日的報告，Tempus AI 被認為是值得投資的 12 大基因組股票之一</p>

Canaccord 下調了 Tempus AI, Inc. (TEM) 的目標價格